Prognostic importance of RASSF2 expression in patients with gastric cancer who had undergone radical gastrectomy


Aydin D., Bilici A., Kayahan S., Yavuzer D., Basar M., ALİUSTAOĞLU M.

CLINICAL & TRANSLATIONAL ONCOLOGY, vol.18, no.6, pp.608-616, 2016 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 18 Issue: 6
  • Publication Date: 2016
  • Doi Number: 10.1007/s12094-015-1405-9
  • Journal Name: CLINICAL & TRANSLATIONAL ONCOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.608-616
  • Kütahya Health Sciences University Affiliated: No

Abstract

Although Ras-association domain family of gene 2 (RASSF2) has been shown to undergo promoter methylation at high frequency in some cancer types and in brain metastases, its clinical utility as a useful prognostic molecular marker remains unclear in gastric cancer.